FDA Inspection 865481 — Teva Canada Limited

Teva Canada Limited — FEI 3002807750

The FDA completed an inspection of Teva Canada Limited on February 14, 2014 in Stouffville. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stouffville (Canada)